When this is over, we need to begin loosening China’s ever-tightening grip on crucial sectors of our economy, security, and economic health. We can start by offering irresistible incentives for businesses to start moving their production facilities out of China. By even hinting at what is mentioned in this story, China has shown itself as unworthy of further investment in its economy as long as their Communist dictatorship remains in power.
The disturbing threats made during a global pandemic as well as the scary consequences if that threat becomes real highlight just how tight China’s grip is on the global supply chain. Already, the Food and Drug Administration has announced the first drug shortage related to the coronavirus. Though it did not disclose which drug was in short supply, the FDA did say it could not access enough raw components needed because they are made in China. That doesn’t come as a surprise to Sen. Marco Rubio, R-Fla, who told Fox News on Thursday that America is “dangerously reliant” on China for the production of critical goods, including parts for technologies needed to fight COVID-19. Though the United States is a global leader in drug discovery, much of the manufacturing has moved overseas. The last American manufacturing plant to make a key component in penicillin shuttered in 2004. Since then, Chinese pharmaceuticals companies have taken over, supplying between 80 percent and 90 percent of U.S. antibiotics, 70 percent of acetaminophen and about 40 percent of heparin, according to Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations.China hints at denying Americans life-saving coronavirus drugs | Fox News